483
Magna Pharmaceuticals IncFDA 483 - Magna Pharmaceuticals Inc - October 29, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Magna Pharmaceuticals Inc. in Louisville, KY, revealed a significant deficiency in their quality system. The firm failed to adequately establish procedures for corrective and preventive actions (CAPA). This indicates a fundamental gap in their ability to address and prevent recurring issues.
- Person
Open in Dashboard
ID · cd0c0bfe-031e-466e-9898-313ff3fc385e